CTLA4 and breast cancer: Furthermore, CACNA2D1 was positively correlated with the expression of CTLA4, TIGIT, and BTLA, but not with the expression of PDCD1 (Figure 12C), indicating that immune checkpoints may also be held responsible for the poor prognosis of BC patients with low expression of CACNA2D1.